Information on genomic profiling, functional imaging, tumor markers (e.g., EZH2, p53, CXCR4, CCR7, Notch-1, E-cadherin, VEGF-C, VEGF-D, VEGFR-3, Prox-1, lymphatic vessel endothelial receptor1, RhoC GTPase) and disease-specific survival was not available in NCDB. The gene discussed is EZH2; the disease is neoplasm.